PubMed · 1980 · 43 citations · 0 references
PharmacyPharmacotherapyAllergyHypersensitivityRhinologyAllergic RhinitisAllergic Rhinitis ManagementAllergic Rhinitis PharmacotherapyNasal Drug DeliveryNasal FormulationsAdult Allergic Rhinitis PharmacotherapyBudesonide TherapyDouble-blind TrialsIntranasal Corticosteroid TherapyNasal SpraysSeasonal Allergic Rhinitis TreatmentSprayTopical Nasal Therapy
39 patients with seasonal rhinitis entered a double-blind study comparing nasal sprays of budesonide 400 micrograms/day and placebo. Symptoms were assessed over a treatment of of three weeks. There were statistically significant differences in favour of the active spray on all measures of assessment. Side effects were mild and the incidence was negligible.